Pralatrexate Is an Effective Treatment for Relapsed or Refractory Transformed Mycosis Fungoides: A Subgroup Efficacy Analysis From the PROPEL Study
Year: 2012
Type: article
Institutions: Yale Cancer Center, Yale University, Memorial Sloan Kettering Cancer Center, Hôpital Lyon Sud, Washington University in St. Louis, City Of Hope National Medical Center, City of Hope, Fox Chase Cancer Center, University of California, Los Angeles, UCLA Jonsson Comprehensive Cancer Center, University of Washington, Weill Cornell Medicine, Centre Hospitalier Universitaire Henri-Mondor, Hôpitaux Universitaires Henri-Mondor, NewYork–Presbyterian Hospital, Columbia University Irving Medical Center
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Celgene, Allos Therapeutics
OpenAlex ID: W2049872202
